Minimizing DKA Risk With SGLT2 Inhibitors in Type 1 DiabetesMinimizing DKA Risk With SGLT2 Inhibitors in Type 1 Diabetes

Could dose titration and ketone monitoring make drugs designed for type 2 diabetes safe in type 1 diabetes? Medscape Diabetes & Endocrinology

Source: Medscape Diabetes Headlines - October 28, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology Commentary Source Type: news